Skip to main content
NeuronFeed Submit a startup

Insilico Medicine vs OpenEvidence

Which Healthcare AI tool is better in 2026?

Insilico Medicine

Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms.

Undisclosed

OpenEvidence

AI medical assistant for clinicians

$735M

Side-by-side

Insilico Medicine OpenEvidence
TaglineAccelerating drug discovery and development through generative AI and advanced bioinformatics platforms.AI medical assistant for clinicians
Founded2022
HQSan Francisco, US
Employees50-200
Total fundingUndisclosed$735M
Latest roundSeries D · Jan 2026
Valuation$12B
Cheapest paid plan Pricing not disclosed
Free plan ✓ Free for Verified US Physicians
Free trial
Top tier price Pricing not disclosed
Pricing summary Enterprise · Contact sales 1 published plans
Categories

Capability matrix

Developer-facing capabilities and access signals for Insilico Medicine and OpenEvidence.

Capability Insilico Medicine OpenEvidence
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages 2 (TypeScript, Python)
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Insilico Medicine

  • Strong in AI Healthcare

🔵 Strengths of OpenEvidence

  • Has raised more capital ($735M vs Undisclosed)
  • Higher Neuron score (60 vs 15)
  • Offers a free plan
  • Newer company (2022)

Which should you choose?

Choose OpenEvidence if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Insilico Medicine vs OpenEvidence — which is better?

It depends on your priority. Insilico Medicine is the leaner option; OpenEvidence has broader feature depth. See the side-by-side table above.

Is Insilico Medicine cheaper than OpenEvidence?

No — OpenEvidence's cheapest paid plan is Free, while Insilico Medicine's is Enterprise · Contact sales.

Do Insilico Medicine and OpenEvidence offer free plans?

Insilico Medicine: Paid only. OpenEvidence: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.